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track trends on an individual and group basis. Therefore,
developing new methods to improve our data prepares us
better for challenges of external audits, such as CIBMTR and
FACT (Foundation for the Accreditation of Cellular Therapy).
N.M. Minas, K. Ruehle. CIBMTR Monthly Internal Assess-
ment Improves Quality of Registry Data. Biology of Blood and
Marrow Transplantation. Volume 18, Issue 2, Supplement,
Page S239, February 2012 [abstract].
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Signature Authentication
Elizabeth Nista. Blood & Marrow Transplant Program, Medical
University of South Carolin, Charleston, SC
Introduction: The written signature as a validation tool has
not kept up with the electronic age. Written signatures are
cumberson, difﬁcult to verify, easy to forge or pre date, and
inﬂexible for staff.
The clinicians signature is a requirement of multiple
accrediting bodies (most notably the Foundation for the
Accreditation of Cellular Therapy), and is needed for internal
and external written agreements, audits, validations, SOPs,
orders and consents. The handwritten signature is an inef-
ﬁcient use of time and with multiple items needed for
signature can be extremely cumbersome. The DM and QM
staff must wait for the document to be reviewed, (either in
the moment or leave the document with the clinician and
keep checking back for completion). The handwritten
signature can be easily forged or pre-dated making its
authenticity questionable.
Due to these factors an electronic signature was imple-
mented in our program using an Adobe digital signature
program. This change was reviewed with our legal depart-
ment and accrediting bodies who determined this was an
acceptable, and preferable, format. The change was as simple
as changing preferences electronically and was able to be
communicated to staff through a mass email. Next, the
documents to be signed were converted to PDF ﬁle format.
Those ﬁles were then sent electronically to the signator/s.
The signator/s then reviewed the documents at their leisure
and returned the document to the originator with the elec-
tronic signature applied.
The PDF format of the document ensures that the infor-
mation contained has not been altered. The electronic
signature uses encryption technology to verify the signer's
digital identity. The signature consists of three components,
each of which can be customized; the signature, signature
details (e.g. an email address or business location), and
a watermark. Each signature includes the real time and date
that the signature was applied making post or pre dating
impossible.
Example:
Conclusion: Workﬂow was dramatically improved with
electronic submission, review, and return of all documents
providing increased ﬂexibility on the part of the staff. There
is a new integrity and authenticity to the signatures due toa higher level of security thru the use of encryption and the
use of a real time and date stamp. Staff, auditors, and
inspectors alike can be assured they are viewing the most
current, authentic, version of any document by reviewing the
signature stamp.
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Five Innovations in BMT Clinical Research Process
Jason D. Sabo, Tiffany Stoudemire, Melissa Yurch,
Sarah Cornman, Sharisa Cross, Tanya Rodela, Shawnda Tench,
Joshua Workman, Matt E. Kalaycio. Department of
Hematologic Oncology and Blood Disorders, Cleveland Clinic
Taussig Cancer Institute, Cleveland, OH
Background: Reporting to the Center for International Blood
and Marrow Transplant Research (CIBMTR) and internal
databases requires process management to ensure accurate
data, validity, reliability, error rate, and outcomes. Status quo
processes that go unchallenged remain inefﬁcient and costly.
Updating our process and targeting best practices has
reduced our critical ﬁeld error rate from 4.2% to 1.7% (CIBMTR
audit, 2008 e 2012). We recommend ﬁve innovative process
areas BMT research centers can begin implementing today
with the goal of continuous process improvement.
Five Areas for Innovation: We are targeting innovation in
the following areas: (a) Technology, (b) Communication (c)
Work ﬂow, (d) Stafﬁng, and (e) Data Reliability.
Technology:
 Converting traditionally paper processes into electronic
data ﬁles and scanning documents into our electronic
medical record.
 Rethinking data storage has increased data security and
saved the department an estimated $934.00 per year.
Communication:
 Establishing standardized internal data collection
forms and information sharing encouraged trans-
parency throughout the clinical team.
 Targeting processes including: lost to follow-up,
CIBMTR research consent, comorbidities and infections,
and Physician sign-off.
Work Flow:
 Identifying both low cost and efﬁcient solutions to
workﬂow barriers.
 Redeﬁning tasks for better time tracking, project
management, and Data Coordinator (DC) training.
 Using student interns to address long term data storage
projects.
Stafﬁng:
 Avoiding costly bad hires and reducing turnover by
selecting DC's with strong research backgrounds.
 Conducting peer interviews to gauge personality ﬁt
with the current research team.
Data Reliability:
 Preventing errors with a multi-level checks and
balances procedure for DC feedback.
 Developing internal training manuals with mutually
exclusive and exhaustive categories to eliminate
disagreements in data coding and entry.
 Future reliability testing to streamline DC training and
increase validity. An intercoder reliability above 80%
will be considered acceptable (Krippendorf, 2007).
Key Element Pre Post
1. Is date time of Infusion Complete ? 84% 98%
Abstracts / Biol Blood Marrow Transplant 19 (2013) S167eS177 S171Future: These good clinical practices are leading to error
reduction and increased data validity. Our objective for the
2016 audit is to demonstrate below 1% total errors and attain
reciprocal data between electronic medical records, internal
databases, and CIBMTR by implementing one innovative
process per quarter.2. Is use of Hydration and Premedications indicated
(time of premeds) ?
68% 100%
3. Is Adverse Events completed ? 74% 100%
4. Is product type and cell dose complete ? 72% 95%
5. Is form signed by and Attending ? 95% 94%
6. Is the Start and Stop times completed ? 78% 98%
7. Are the vital sings completed per policy ? 67% 59%
Overall Results 77% 92%TRANSPLANT NURSING-ADMINISTRATION ORAL
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Implementation of an Electronic Form for Hematopoietic
Stem Cell Transplant (HSCT) Infusions Improves
Documentation Compliance
Karen Collum. Nursing, Memorial Sloan - Kettering Cancer
Center, New York, NY
Background: Historically, Hematopoietic Stem Cell (HSC)
Infusionwas documented on a standard paper form available
from a document library throughout the institution. Once
complete, the form remained in the patient's chart until
discharge at which time the chart was scanned into the EMR.
This limited the availability and portability of the informa-
tion. Completion of this form was the responsibility of the
clinician infusing the HSC product. Additionally, HSC infu-
sions are conducted in a variety of units throughout MSKCC.
These areas have been divided into 5 major groups.
The Bone Marrow Transplant Quality Assessment
Committee (BMT QAC) conducted a compliance audit of
infusion documentation. The timeframe used for the audit
was October 2010 through March 2011, which included
a total of 194 transplants. A random selection of 50 trans-
plants (10 from each major group) during this 6 month
period was reviewed; resulting in a total of 60 forms (10 of
which were double cord transplants requiring 2 forms).
Seven key elements of the form were identiﬁed based on
regulatory and institutional requirements and audited for
completeness. The results of the audit indicated that docu-
mentation compliance was 77%.
Intervention: To improve documentation compliance of HSC
Infusions, we developed an electronic infusion form. The
building and testing of the form lasted approximately one
year. Simultaneously, we modiﬁed our vital sign monitoring
parameters for better standardization between different cell
types. During this time period, infusion Standard Operating
Procedure (SOP) was revised to incorporate use of the elec-
tronic document and standardized vital sign parameters. The
design of the electronic form required all ﬁelds to be
complete prior to ﬁnal electronic signature and acceptance of
the form. Additionally, Infusion vitals entered into the elec-
tronic ﬂowsheet by the RN were imported into the note by
the documenting clinician. Subsequent to distribution of the
SOP and training of Stem Cell Transplant service (Physicians,
Nurse Practitioners, Registered Nurses and Cell Processing
Technicians) the form went live in March 2012. Three weeks
post roll out to all areas, the paper form was removed from
the document library; however the form will be available
during system downtime.
Outcome: A follow up audit was conducted to measure
compliance post implementation of electronic documenta-
tion. The timeframe for the audit was April 2012 through July
2012, a total of 209 transplants. Similar to the pre-imple-
mentation audit, a random selection of 50 transplants from
the 5 major groups during this 4 month period were
reviewed for a total of 60 forms. The same 7 key elements of
the form were audited for completeness. The results of the
post implementation audit indicated that compliance ofdocumentation improved from 77% to 92%, an improvement
of 15%.113
Blood and Marrow Transplant (BMT) Outreach
Presentation Promoting BMT Nursing As a Career Choice:
Pre and Post Survey Results
Kim Schmit-Pokorny 1, Ellen Denzen 2, Rosemary Ford 3,
Martha Lassiter 4, Terry Sylvanus 5,
Alexandra De Kesel Lofthus 6, Elizabeth Murphy 7,
Joyce Neumann 8. 1 Oncology/Hematology, Blood and Marrow
Transplantation, University of Nebraska Medical Center,
Omaha, NE; 2 Patient Services, National Marrow Donor
Program (NMDP); 3 Transplant Clinic, Seattle Cancer Care
Alliance, Seattle, WA; 4Division of Cellular Therapy, Duke
University Health System, Durham, NC; 5Mofﬁtt Cancer Center,
Tampa, FL; 6 Case Management, National Marrow Donor
Program, Minneapolis, MN; 7 Patient Services, National
Marrow Donor Program, Minneapolis, MN; 8 Stem Cell
Transplantation and Cellular Therapy, University of Texas
MDAnderson Cancer Center, Houston, TX
The System Capacity Initiative (SCI), sponsored by the
National Marrow Donor Program (NMDP), was convened to
evaluate and provide recommendations for addressing
workforce and infrastructure challenges for current and
future utilization of blood andmarrow transplant (BMT). The
Nursing Workforce Group (NWG) was established to address
projected shortages of BMT nurses. After surveying BMT
nurses, the NWG identiﬁed several priority challenges,
including the recruitment of nurses to the BMT ﬁeld. In an
effort to increase the number of BMT nurses, an outreach
presentation entitled ‘Introduction to BMT' was developed
and delivered to nursing students throughout the U.S. The
one-hour presentation describes the BMT process, identiﬁes
various nursing roles in BMT, and describes the beneﬁts of
working in this area. A brief pre and post survey is admin-
istered to assess the students' change in awareness of BMTas
a career option, nursing career preferences, likelihood of
pursuing a BMT career, and previous education/training in
BMT after listening to the presentation. To date, the presen-
tation, and pre and post surveys, was delivered to a total of
181 nursing students. The majority of students had not
previously considered a career in BMT (56.9%). However, the
presentation signiﬁcantly increased nursing students'
interest in pursuing a BMT career (N¼61; P < .0001). Addi-
tionally, students' indicated that ‘feeling valued' (62.5%),
‘intellectual stimulation' (66.3%), ‘emotional gratiﬁcation of
providing patient care' (69.5%) and ‘interest in subject
matter' (69.5%) were very important career aspects (see
Figure 1). The NWG in partnership with Oncology Nursing
Society (ONS) and American Society for Blood and Marrow
Transplantation (ASBMT) is continuing to promote the
presentation to increase awareness of BMT nursing as
a career option. It will be available for professional
